BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 83 positions · Total reported value $2.54B · Top-10 concentration 32.8% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, BRAIDWELL LP disclosed 83 equity positions with a combined reported value of $2.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 32.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were CAI ($147.12M), HNGE ($110.40M), GKOS ($82.73M). By sector, the heaviest allocations are Health Care 90.1%, Technology 4.3%. Versus the prior quarter, allocation shifted toward Health Care (+4.8pp), Technology (+2.2pp) and away from Consumer Staples (-0.8pp), Other (-8.1pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q2 2026 were HUM ($45.48M), MAZE ($34.02M), AVTX ($30.11M).

Of the 25 positions fully exited versus the prior quarter, the largest were CNTA ($78.91M), NUVL ($71.76M), CGON ($66.65M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • HUM HUMANA INC COM · $45.48M
  • MAZE MAZE THERAPEUTICS INC · $34.02M
  • AVTX AVALO THERAPEUTICS INC · $30.11M
  • ALMR ALAMAR BIOSCIENCES INC · $29.37M
  • ORKA ORUKA THERAPEUTICS INC · $26.47M
  • AVLN AVALYN PHARMA INC · $26.38M
  • IMCR IMMUNOCORE HLDGS PLC · $16.55M
  • OVID OVID THERAPEUTICS INC · $15.92M

Fully Exited (vs previous quarter)

  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $78.91M
  • NUVL NUVALENT INC · prev qtr: $71.76M
  • CGON CG ONCOLOGY INC · prev qtr: $66.65M
  • APGE APOGEE THERAPEUTICS INC · prev qtr: $40.29M
  • PEN PENUMBRA INC · prev qtr: $34.59M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $32.12M
  • ILMN ILLUMINA INC COM · prev qtr: $28.25M
  • BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $28.08M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 90.1%
Technology 4.3%
Financials 0.9%
Other 0.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.26M $147.12M 5.79%
5.79%
Add
2 1.33M $110.40M 4.34%
4.34%
Reduce
3 591.93K $82.73M 3.25%
3.25%
Reduce
4 2.00M $81.14M 3.19%
3.19%
Reduce
5 879.47K $78.08M 3.07%
3.07%
Reduce
6 654.26K $77.82M 3.06%
3.06%
Add
7 1.79M $69.63M 2.74%
2.74%
Reduce
8 1.13M $68.29M 2.69%
2.69%
Reduce
9 2.45M $59.33M 2.33%
2.33%
Reduce
10 594.56K $57.96M 2.28%
2.28%
Reduce
11 336.17K $56.66M 2.23%
2.23%
Reduce
12 6.53M $56.50M 2.22%
2.22%
Add
13 3.28M $55.40M 2.18%
2.18%
Reduce
14 8.70M $54.31M 2.14%
2.14%
Reduce
15 128.97K $47.94M 1.89%
1.89%
Reduce
16 114.50K $45.48M 1.79%
1.79%
New
17 89.39K $44.82M 1.76%
1.76%
Reduce
18 378.16K $43.36M 1.71%
1.71%
Add
19 381.13K $42.32M 1.67%
1.67%
Add
20 1.62M $42.15M 1.66%
1.66%
Add
21 1.65M $41.65M 1.64%
1.64%
Reduce
22 596.75K $41.62M 1.64%
1.64%
Reduce
23 609.72K $40.50M 1.59%
1.59%
Add
24 710.88K $39.24M 1.54%
1.54%
Reduce
25 2.80M $36.48M 1.44%
1.44%
Add
26 1.22M $34.79M 1.37%
1.37%
Reduce
27 1.14M $34.02M 1.34%
1.34%
New
28 483.82K $33.96M 1.34%
1.34%
Reduce
29 1.14M $33.71M 1.33%
1.33%
Add
30 473.62K $33.06M 1.30%
1.30%
Add
31 2.13M $31.77M 1.25%
1.25%
Add
32 1.29M $31.22M 1.23%
1.23%
Reduce
33 677.57K $30.23M 1.19%
1.19%
Hold
34 1.63M $30.11M 1.19%
1.19%
New
35 1.08M $29.37M 1.16%
1.16%
New
36 150.63K $28.69M 1.13%
1.13%
Add
37 70.14K $27.89M 1.10%
1.10%
Reduce
38 278.16K $26.47M 1.04%
1.04%
New
39 801.39K $26.38M 1.04%
1.04%
New
40 3.07M $26.27M 1.03%
1.03%
Add
41 1.03M $25.32M 1.00%
1.00%
Reduce
42 587.57K $25.08M 0.99%
0.99%
Add
43 564.72K $24.23M 0.95%
0.95%
Add
44 3.98M $23.48M 0.92%
0.92%
Hold
45 147.85K $22.18M 0.87%
0.87%
Reduce
46 3.16M $21.90M 0.86%
0.86%
Add
47 79.50K $21.58M 0.85%
0.85%
Reduce
48 1.10M $21.05M 0.83%
0.83%
Hold
49 53.96K $20.87M 0.82%
0.82%
Reduce
50 596.90K $20.52M 0.81%
0.81%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 60% R 60% F1 60% (modelled on 2026-Q1; 6/10 hit)

Low-confidence forecast This fund replaces about 31% of its Top-10 each quarter and backtests at F1 67% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 67% · recall 67% · F1 67% · avg rank error 2.9 · Top-10 turnover 31%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 40% 40% 40% ASND · HSCS · NVCR · NBIX · PCVX · PODD · XENE · TNDM · PEN · DAWN HSCS · NVCR · APGE · NBIX · ARGX · PCVX · NEO · DXCM · LEGN · INSM
2024-Q2 60% 60% 60% APGE · HSCS · NVCR · NBIX · ARGX · NEO · PCVX · LEGN · DXCM · PEN NVCR · NBIX · CGON · XENE · APGE · NEO · GH · PODD · LEGN · DXCM
2024-Q3 80% 80% 80% NVCR · CGON · XENE · APGE · NBIX · NEO · GH · LEGN · DXCM · PODD NVCR · CGON · XENE · NBIX · NEO · APGE · APLS · ALGN · GH · LEGN
2024-Q4 90% 90% 90% CGON · NVCR · XENE · NBIX · APLS · NEO · APGE · ALGN · KNSA · GH NVCR · NBIX · XENE · NEO · LEGN · CGON · GH · ALGN · APGE · KNSA
2025-Q1 70% 70% 70% NVCR · NBIX · XENE · LEGN · NEO · CGON · GH · ALGN · APLS · KNSA NVCR · NBIX · LEGN · ARGX · XENE · TTMI · NEO · ALGN · CGON · KRYS
2025-Q2 80% 80% 80% NVCR · NBIX · LEGN · ARGX · XENE · ALGN · TTMI · NEO · KRYS · CGON CAI · NBIX · NVCR · XENE · ARGX · KRYS · ALGN · LEGN · TTMI · NUVL
2025-Q3 60% 60% 60% CAI · NBIX · NVCR · ARGX · XENE · KRYS · NUVL · ALGN · IRWD · LEGN GH · CAI · NVCR · XENE · CGON · NBIX · KRYS · NUVL · SLNO · TTMI
2025-Q4 70% 70% 70% GH · NVCR · CAI · XENE · CGON · NBIX · KRYS · EWTX · NUVL · SLNO CAI · GH · EWTX · NBIX · GKOS · NUVL · XENE · CGON · TTMI · HNGE
2026-Q1 60% 60% 60% GH · CAI · EWTX · GKOS · NBIX · NUVL · XENE · CGON · TTMI · HNGE CAI · NBIX · GKOS · CNTA · XENE · DNTH · EWTX · IRTC · NUVL · KOD
2026-Q2 ★ 60% 60% 60% CAI · NBIX · GKOS · IRTC · DNTH · CNTA · XENE · ARGX · EWTX · NUVL CAI · HNGE · GKOS · EWTX · SYRE · IRTC · KOD · XENE · GLUE · DNTH

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did BRAIDWELL LP buy in 2026-Q2?

In its 2026-Q2 13F filing, BRAIDWELL LP reported 83 equity positions worth $2.54B in aggregate; its largest disclosed positions were CAI ($147.12M), HNGE ($110.40M), GKOS ($82.73M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $2.54B of long equity holdings across 83 positions as of 2026-Q2. Top-10 holdings account for 32.8% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →